Shares of Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) were down 13.6% during mid-day trading on Thursday . The company traded as low as $15.21 and last traded at $15.21. Approximately 900 shares traded hands during mid-day trading, a decline of 81% from the average daily volume of 4,858 shares. The stock had previously closed at $17.60.
Shionogi & Co., Ltd. Stock Down 13.6%
The stock has a 50 day simple moving average of $16.77 and a 200-day simple moving average of $17.04.
Shionogi & Co., Ltd. Company Profile
Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.
Featured Stories
- Five stocks we like better than Shionogi & Co., Ltd.
- How to Invest in the FAANG Stocks
- The Trade Desk: After a 70% Plunge, This Could Be The Time to Buy
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF
- The How And Why of Investing in Oil Stocks
- Strong Quarter, Weak Reaction: Why GitLab Shares Dropped
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
